BioCentury
ARTICLE | Clinical News

Protein Design Labs regulatory update

June 7, 1993 7:00 AM UTC

Protein Design Labs Inc. (PDLI) Protein Design Labs Inc. (PDLI) has been granted Orphan Drug Designation for its human antibodies against cytomegalovirus (CMV) and hepatitis B for certain indications...